Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Arzneimittel-Forschung|May 1, 1990
Isolation and structural elucidation of biotransformation products from acarboseM Boberg, J Kurz, H J Ploschke, et al.
Journal of Hepatology|April 27, 2001
Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitisK A Fleming, K M Boberg, H Glaumann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998
Biotransformation of cerivastatin in mice, rats, and dogs in vivoM Boberg, R Angerbauer, W K Kanhai, et al.
Scandinavian Journal of Gastroenterology|August 1, 1994
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitisK M Boberg, E Schrumpf, O Fausa, et al.
Endoscopy|July 13, 2010
Validation of a cholangiographic prognostic model in primary sclerosing cholangitisC Y Ponsioen, J B Reitsma, K M Boberg, et al.
Diabetologia|April 1, 1984
Effects of an increased content of cereal fibre in the diet of Type 2 (non-insulin-dependent) diabetic patientsB Karlström, B Vessby, N G Asp, et al.
Clinical Transplantation|March 19, 2010
Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based studySzilveszter Dolgos, Anders Hartmann, Gunnhild Aker Isaksen, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitisK M Boberg, O Fausa, T Haaland, et al.
Tissue Antigens|June 16, 2006
The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patientsE Melum, T H Karlsen, U Broomé, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involvedM Boberg, R Angerbauer, P Fey, et al.
Pageof 12